Upper urinary tract cancer drug may offer long-term benefits
While randomized comparative trials are needed, a relatively new treatment option for upper urinary tract cancers shows ...
HealthDay on MSN6d
ASTRO Issues Clinical Guideline for Use of Radiation Therapy in Anal Cancer
In a clinical practice guideline issued by the American Society for Radiation Oncology and published online Feb. 27 in ...
Renal & Urology News11d
Mitomycin Gel Provides Durable Response in Low-Grade UTUC
Mitomycin C gel instillation is a nonsurgical, kidney-sparing primary treatment option for patients with low-grade upper tract urothelial carcinoma (UTUC).
UroToday5d
SES AUA 2025: Long-Term Outcomes of Primary Chemoablation of Low-Grade UTUC with UGN-101, a Mitomycin Reversal Thermal Gel
Patients with low-grade upper tract urothelial carcinoma receiving primary treatment with 6 once-weekly pyelocalyceal doses ...
Ophthalmology Times24y
The search for an antifibrotic drug for use with pediatric glaucoma devices
Kohen's team explored pirfenidone (PFD) for its antifibrotic activity, aiming to reduce scarring around GDDs without the ...
Medscape22d
Use of Mitomycin C in Dacryocystorhinostomy: A Report by the American Academy of Ophthalmology.
PURPOSE: To review the literature on the adjuvant use of mitomycin C (MMC) during dacryocystorhinostomy (DCR) in adults with primary nasolacrimal duct obstructions (NLDOs) to determine the ...
Business Wire12d
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
These new team members will support the ongoing commercialization of Jelmyto ® (mitomycin) for pyelocalyceal solution, UroGen’s first approved product, and the continued development of the ...